Aplagon Doses First Patient in Phase 2a Trial for...
Category : Clinical Trial Update 16 March 2026Clinical-stage biotech Aplagon has reached an important milestone in its pipeline for thrombo-inflam...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Meiji Seika Pharma Begins Phase I Trial of PD-1 Ag...
Category : Clinical Trial Update 16 March 2026Japanese pharmaceutical company Meiji Seika Pharma Co., Ltd. has initiated a Phase I clinical trial...
NIH Awards $2.5M Grant to Amydis to Develop Eye Te...
Category : Clinical Trial Update 14 March 2026Early detection remains one of the biggest challenges in neurodegenerative diseases. Conditions like...
Abbott Laboratories Launches ICRAS Tool to Help Do...
Category : Clinical Trial Update 13 March 2026Managing diabetes is not only about controlling blood sugar. For millions of patients, the real dang...
ImmunoBrain to Present Phase 1b Data for Alzheimer...
Category : Clinical Trial Update 13 March 2026New approaches to treating neurodegenerative diseases are increasingly focusing on the role of the i...
Latest Newsletter Post
-
Meiji Seika Pharma Begins Phase I T..
16 March 2026
-
Aplagon Doses First Patient in Phas..
16 March 2026
-
NIH Awards $2.5M Grant to Amydis to..
14 March 2026
-
Inimmune Corporation Advances Phase..
13 March 2026
-
ImmunoBrain to Present Phase 1b Dat..
13 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com